BioDriveAFS Trial
York Trials Unit, University of York
United Kingdom
Abbie joined YTU in June 2022 as a Trainee Statistician. She conducts/supports statistical analysis of trials. Undertake programming for randomisation and summarising data.
BioDriveAFS Trial
Liverpool University Teaching Hospitals NHS FT
United Kingdom
Alex is a Consultant Microbiologist at Liverpool University Hospitals NHS Foundation Trust. He has numerous peer-reviewed publications, including the recent CON: Serum biomarker monitoring should not replace primary antifungal chemoprophylaxis in patients with acute leukaemia receiving systemic anti-cancer therapy he co-authored with Professor William Hope.
BioDrive AFS Trial
University of York
United Kingdom
Andrea is a pharmacist who has previously worked in primary care and in community pharmacy, she is a Reader and Non-Medical prescribing programme director in the Faculty of Health Sciences at the University of Hull. She gained her undergraduate degree (first class honours) in pharmacy from the University of Bradford in 1999, before completing an MSc in clinical pharmacy while working in secondary care. Andrea completed her PhD in 2006 while working on the MRC-funded RESPECT trial. Her PhD was titled Development and Validation of a UK Medication Appropriateness Index. Andrea has been active in research since 2006 particularly in the field of dementia research, community pharmacy and medication/prescribing. Andrea is delighted to be working with the team on BIODrive.
BioDrive AFS Trial
York Trials Unit, University of York
United Kingdom
-
BioDrive AFS Trial
York Trials Unit
United Kingdom
-
BioDrive AFS Trial
University of Hull
United Kingdom
Dr David Allsup is Senior Lecturer in Haematology at the Hull York Medical School and an Honorary Consultant Haematologist with the Hull University Teaching Hospital. He undertook his haematology specialist training in Liverpool and was subsequently appointed as a Clinical Lecturer in Haematology with the University of Liverpool in 2001. During this period he undertook research into the role of B-cell receptor signalling in the pathogenesis of chronic lymphocytic leukaemia which ultimately formed the basis of a PhD which was awarded in 2004. In 2004 he commenced work as a Consultant Haematologist in Hull University Teaching Hospital Trust. His clinical work in Hull encompassed all subspeciality areas but with particular emphasis on lymphoid malignancies and haemostasis. These clinical interests supported ongoing research into chronic lymphocytic leukaemia both within the University of Hull and with external collaborators, notably Professor J Allan of the University of Newcastle. In 2018 he was appointed as Senior Lecturer in the University of Hull where he continues to develop research interests in haematological malignancies and supportive care. Dr Allsup is a Fellow of the Royal College of Pathologists, Member of the United Kingdom Haemophilia Centre Directors Organisation, Member of the UK CLL Forum, a member of the NCRN CLL clinical trials subgroup and a Fellow of the Higher Education Academy. As well as being joint chief investigator on BioDriveAFS he is chief investigator on a registry study of acute leukaemia in pregnancy and co-investigator on FLAIR and STATIC, phase III studies in chronic lymphocytic leukaemia. He has authored and co-authored more than 70 peer-reviewed articles and book chapters and has presented his work nationally and internationally
BioDrive AFS Trial
York Trials Unit, University of York
United Kingdom
Professor David Torgerson is a health economist and trial methodologist with over 400 publications, including the book ‘Designing Randomised Controlled Trials in Health, Education and the Social Sciences (Palgrave Macmillan, 2008). As well as working on health care trials he also contributes to the design and conduct of randomised trials across the social sciences and is a joint organiser of the Annual Conference in Trials in the Social Sciences.
BioDriveAFS trial
York Trials Unit, University of York
United Kingdom
Ellie has experience within the field of exercise and health and wellbeing holding the role of an inclusion assistant at a football club charity foundation. She also completed a research internship with the NIHR focusing on the physical activity interventions for improving public mental health delivered by local authorities and third-sector organisations.
BioDrive AFS Trial
Hull York Medical School
United Kingdom
Gavin is an academic infection consultant at Hull York Medical School (HYMS) and University of York and has more than 15 years of experience in senior clinical and academic practice including in orthopaedic infection, successful leadership of antimicrobial stewardship at Hull University Teaching Hospitals (HUTH) [2005-2018], and international antimicrobial stewardship education. He has been involved in practice changing UK multi-centre trials in infection such as OVIVA and ARREST, is co-Chief Investigator of BioDriveAFS, provided leadership in the local research response to COVID-19 and the development of the Infection Research Group (IRG) at HUTH, and has >100 peer reviewed publications. Research experience is broad, including translational, quantitative, qualitative, and quality improvement methods.
BioDrive AFS Trial
British Society for Antimicrobial Chemotherapy (BSAC)
United Kingdom
Dr Jacqueline Sneddon is Programmes Manager for the British Society for Antimicrobial Chemotherapy (BSAC), a learned society dedicated to supporting education on infection and antimicrobial use. In this role she leads UK and global projects on antimicrobial stewardship. She is a Fellow of the Royal Pharmaceutical Society (RPS), a member of the RPS Scottish Pharmacy Board and in 2021 was successful in being credentialed by the RPS as a Consultant Pharmacist. From 2008-2021 Jacqueline was the Project Lead for the Scottish Antimicrobial Prescribing Group (SAPG) which leads the national antimicrobial stewardship programme. She has served on several national HAI and AMR groups, chaired an update of the SIGN UTI guideline, and contributed as an expert to NICE guidelines. Jacqueline is widely published on antimicrobial stewardship, has been an invited speaker at UK and international conferences and is a peer reviewer for several infection and pharmacy journals. During 2019 - 2021, Jacqueline led a multi-professional team awarded a global volunteering grant from the Fleming Fund that supported two hospitals in Ghana to establish antimicrobial stewardship.
BioDrive AFS Trial
Hull University Teaching Hospitals NHS FT
United Kingdom
-
BioDriveAFS Trial
York Trials Unit, University of York
United Kingdom
Karen joined York Trials Unit in 2020 as a Patient and Public Involvement (PPI) and Stakeholder Engagement Manager. She previously worked as an independent communications consultant for a wide variety of clients in the public and private sector. Karen started her career in the Netherlands, where she was employed as a senior communications and media relations officer by local councils and the Dutch pension fund APG.
BioDrive AFS Trial
York Trials Unit, University of York
United Kingdom
Lydia is a Trial Coordinator for York Trials Unit but prior to that she was working as a Trial Support Officer in the unit since joining in January 2018. She currently works mainly on surgical trials.
BioDrive AFS Trial
Hull University Teaching Hospitals NHS FT
United Kingdom
Dr Patrick Lillie is a consultant in Infectious Diseases and hon senior lecturer at Hull Teaching Hospitals / Hull York Medical School. I qualified from Leicester University and trained in general medicine and infectious diseases in Birmingham, Hull & Sheffield, together with research in Oxford. After consultant posts in Mansfield and Southampton I moved posts to Hull in 2017. My clinical interests are infections in haemato-oncology patients, tuberculosis and bacterial infections in people who inject drugs. Research areas include vaccinology, consequences of blood stream infection and severity assessment in severe infection
BioDrive AFS Trial
York Trials Unit, University of York
United Kingdom
Puvan joined the York Trials Unit in 2010 after first training is as a Pharmacist. His post-graduate work prepared him for a broad range of functions relating to the design and conduct of clinical trials along with the synthesis of medical and health-related evidence.
BioDrive AFS Trial
York Trials Unit, University of York
United Kingdom
Sam is a Research Fellow/Trial Manager based at York Trials Unit. Sam previously managed the SPACES programme of research which aims to co-produce an intervention to support people with severe mental ill health to take part in physical activity. Prior to this, Sam coordinated a number of large national multi-centre trials, including the Covid-19 Urgent Public Health Study BASIL (Behavioural Activation in Social Isolation) which aimed to rapidly develop a feasible, acceptable, clinical and cost-effective brief psychological intervention (behavioural activation) to improve depression and loneliness in older adults with physical-mental multi-morbidity during isolation. Sam is an experienced mixed methods health researcher, who joined the University of York in 2013. Sam spent eighteen months as a trial/study support officer in the Mental Health and Addiction Research Group before completing a PhD exploring the sexual health and behaviour of people with severe mental illness. Part way through her PhD Sam joined the York Trials Unit and Statistics research group and spent 4 years working as Research Fellow (trial coordinator).
BioDriveAFS Trial
Kings College Hospital NHS Foundation Trust
United Kingdom
Shreyans is a consultant Haematologist at Kings College Hospital NHS Trust, London with a special interest in myeloid disorders and bone marrow failure, including their treatments such as stem cell transplantation and other novel/cellular therapies
BioDrive AFS Trial
Hull University Teaching Hospitals NHS FT
United Kingdom
Tom is a specialist trainee in infection and clinical research fellow at Hull University Teaching Hospitals. He has an interest in antimicrobial stewardship and has been involved in infection-related trials such as RECOVERY and PRONTO. He is currently studying the role of the microbiome in invasive fungal infection at the Hull York Medical School.
BioDrive AFS Trial
BSAC
United Kingdom
25 years as a senior executive working within the health sector and civil service.
BioDrive AFS Trial
University of Liverpool
United Kingdom
William Hope (BMBS, FRACP, FRCPA, PhD), is Dame Sally Davies Chair of Antimicrobial Resistance (AMR) Research at the University of Liverpool in the UK. Professor Hope is a Fellow of the Royal Australasian College of Physicians and a Fellow of the Royal College of Pathologists of Australasia.